Results
|
|
5241.
|
|
|
|
5242.
|
|
|
|
5243.
|
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy. [electronic resource] by
- Heng, D Y
- Mackenzie, M J
- Vaishampayan, U N
- Bjarnason, G A
- Knox, J J
- Tan, M H
- Wood, L
- Wang, Y
- Kollmannsberger, C
- North, S
- Donskov, F
- Rini, B I
- Choueiri, T K
Producer: 20120920
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
5244.
|
|
|
|
5245.
|
|
|
|
5246.
|
|
|
|
5247.
|
|
|
|
5248.
|
|
|
|
5249.
|
|
|
|
5250.
|
|
|
|
5251.
|
|
|
|
5252.
|
|
|
|
5253.
|
|
|
|
5254.
|
|
|
|
5255.
|
|
|
|
5256.
|
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. [electronic resource] by
- Yamamoto, Hirofumi
- Kondo, Motoi
- Nakamori, Shoji
- Nagano, Hiroaki
- Wakasa, Ken-Ichi
- Sugita, Yurika
- Chang-De, Jin
- Kobayashi, Shogo
- Damdinsuren, Bazarragchaa
- Dono, Keizo
- Umeshita, Koji
- Sekimoto, Mitsugu
- Sakon, Masato
- Matsuura, Nariaki
- Monden, Morito
Producer: 20030925
In:
Gastroenterology vol. 125
Availability: No items available.
|
|
|
5257.
|
|
|
|
5258.
|
|
|
|
5259.
|
|
|
|
5260.
|
|